Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Abridge
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedPrivately held
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Apr 2026: a class action filed against Sutter Health alleges patients were not clearly told their consultations would be recorded through Abridge's ambient AI platform; Abridge is not reported as a defendant and no response was reported.
Cyber & information governance
Apr 2026: a California class action against Sutter Health alleges recording and sharing of patient conversations via Abridge's platform without clear notice (privacy claims); no data breach involving Abridge found in HSH's search. NHS DSPT status not yet checked.
Regulatory & clinical safety
AI clinical documentation software supplier; no regulatory or clinical safety actions involving Abridge found in HSH's search of the last 24 months.
Contract performance
Sep 2026: the US Department of Veterans Affairs selected Abridge (alongside Knowtex) under a multi-vendor ambient AI enterprise contract with a shared ceiling of $775.72m, following pilots from Oct 2025.
Competitors
No competitors linked yet.